Protodesnitazene
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia, the United Kingdom and Finland, first appearing in early 2025.[1][2][3][4][5][6][7][8]
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H31N3O |
| Molar mass | 365.521 g·mol−1 |
| 3D model (JSmol) | |
| |
| |